Note H - Segment Information (Tables)

9 Months Ended

Mar. 31, 2026

Notes Tables

Segment Reporting [Table Text Block]

									Natural
						Corporate			Alternatives
	Private-label			Patent and		expenses			International
	contract			trademark		not allocated			Inc.
	manufacturing			licensing		to segments			Consolidated
Net sales	$	33,809		$	1,673	$	-		$	35,482
Cost of goods sold		34,619			480		-			35,099
Gross profit		(810	)		1,193		-			383
Selling, general and administrative expenses		1,469			649		2,279			4,397
(Loss) income from operations		(2,279	)		544		(2,279	)		(4,014	)
Other (expense) income:
Interest expense		(270	)		-		-			(270	)
Foreign exchange loss		50			-		-			50
Other, net		(9	)		-		-			(9	)
Total other expense		(229	)		-		-			(229	)
(Loss) income before income taxes		(2,508	)		544		(2,279	)		(4,243	)
Provision for income taxes										68
Net loss									$	(4,311	)
Other supplemental information:
Stock-based compensation	$	128		$	12	$	-		$	140
Depreciation and amortization		1,192			2		-			1,194
Capital expenditures		1,100			-		-			1,100

									Natural
						Corporate			Alternatives
	Private-label			Patent and		expenses			International
	contract			trademark		not allocated			Inc.
	manufacturing			licensing		to segments			Consolidated
Net sales	$	102,678		$	5,329	$	-		$	108,007
Cost of goods sold		98,989			1,747		-			100,736
Gross profit		3,689			3,582		-			7,271
Selling, general and administrative expenses		4,341			1,757		6,750			12,848
(Loss) income from operations		(652	)		1,825		(6,750	)		(5,577	)
Other income (expense):
Interest income		30			-		-			30
Interest expense		(720	)		-		-			(720	)
Foreign exchange loss		(445	)		-		-			(445	)
Other, net		(59	)		-		-			(59	)
Total other expense		(1,194	)		-		-			(1,194	)
(Loss) income before income taxes		(1,846	)		1,825		(6,750	)		(6,771	)
Provision for income taxes										384
Net loss									$	(7,155	)
Other supplemental information:
Stock-based compensation	$	452		$	43	$	-		$	495
Depreciation and amortization		3,521			5		-			3,526
Capital expenditures		3,064			-		-			3,064

									Natural
						Corporate			Alternatives
	Private-label			Patent and		expenses			International
	contract			trademark		not allocated			Inc.
	manufacturing			licensing		to segments			Consolidated
Net sales	$	27,075		$	1,691	$	-		$	28,766
Cost of goods sold		26,415			525		-			26,940
Gross profit		660			1,166		-			1,826
Selling, general and administrative expenses		1,216			432		2,278			3,926
(Loss) income from operations		(556	)		734		(2,278	)		(2,100	)
Other income (expense):
Interest income		51			-		-			51
Interest expense		(246	)		-		-			(246	)
Foreign exchange gain		(339	)		-		-			(339	)
Other, net		(8	)		-		-			(8	)
Total other expense		(542	)		-		-			(542	)
(Loss) income before income taxes		(1,098	)		734		(2,278	)		(2,642	)
Benefit for income taxes										(456	)
Net loss									$	(2,186	)
Other supplemental information:
Stock-based compensation	$	222		$	23	$	-		$	245
Depreciation and amortization		1,137			2		-			1,139
Capital expenditures		802			-		-			802

									Natural
						Corporate			Alternatives
	Private-label			Patent and		expenses			International
	contract			trademark		not allocated			Inc.
	manufacturing			licensing		to segments			Consolidated
Net sales	$	90,021		$	5,973	$	-		$	95,994
Cost of goods sold		88,332			1,908		-			90,240
Gross profit		1,689			4,065		-			5,754
Selling, general and administrative expenses		4,045			1,620		6,805			12,470
(Loss) income from operations		(2,356	)		2,445		(6,805	)		(6,716	)
Other income (expense):
Interest income		125			-		-			125
Interest expense		(703	)		-		-			(703	)
Foreign exchange loss		(616	)		-		-			(616	)
Other, net		(11	)		-		-			(11	)
Total other expense		(1,205	)		-		-			(1,205	)
(Loss) income before income taxes		(3,561	)		2,445		(6,805	)		(7,921	)
Benefit for income taxes										(1,562	)
Net loss									$	(6,359	)
Other supplemental information:
Stock-based compensation	$	725		$	73	$	-		$	798
Depreciation and amortization		3,395			5		-			3,400
Capital expenditures		2,159			-		-			2,159

Segment Reporting, Reconciliation of Asset by Segment to Consolidated [Table Text Block]

	March 31, 2026		June 30, 2025
Private-label contract manufacturing	$	114,579	$	113,843
Patent and trademark licensing		40,301		38,096
Total Assets	$	154,880	$	151,939